Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities

  • Sara Azhari Mohamed
  • , Linda Howard
  • , Veronica McInerney
  • , Amjad Hayat
  • , Janusz Krawczyk
  • , Sean Naughton
  • , Andrew Finnerty
  • , Miriam Holohan
  • , Aoife Duffy
  • , Tony Moloney
  • , Eamon Kavanagh
  • , Paul Burke
  • , Aaron Liew
  • , Muhammad Tubassam
  • , Stewart Redmond Walsh
  • , Timothy O'Brien

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science